drugset / Trial / NCT05326490
Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy
Timeline
- Start
- 2022-05-30
- Primary completion
- 2024-09-24
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PB-201 | Unknown | 100 mg | Oral |
| Background | Metformin | Small molecule | — | — |